NO165916C - Analogifremgangsmaate for fremstilling av terapeutisk aktive, ikke-aromatiske fluorallylamin mao-inhibitorer. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive, ikke-aromatiske fluorallylamin mao-inhibitorer.

Info

Publication number
NO165916C
NO165916C NO864869A NO864869A NO165916C NO 165916 C NO165916 C NO 165916C NO 864869 A NO864869 A NO 864869A NO 864869 A NO864869 A NO 864869A NO 165916 C NO165916 C NO 165916C
Authority
NO
Norway
Prior art keywords
fluorallylamine
mao
inhibitors
aromatic
preparation
Prior art date
Application number
NO864869A
Other languages
English (en)
Norwegian (no)
Other versions
NO864869L (no
NO864869D0 (no
NO165916B (no
Inventor
Philippe Bey
Ian A Mcdonald
Michael G Palfreyman
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO864869D0 publication Critical patent/NO864869D0/no
Publication of NO864869L publication Critical patent/NO864869L/no
Publication of NO165916B publication Critical patent/NO165916B/no
Publication of NO165916C publication Critical patent/NO165916C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/24Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/46Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO864869A 1985-12-05 1986-12-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive, ikke-aromatiske fluorallylamin mao-inhibitorer. NO165916C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/805,506 US4650907A (en) 1985-12-05 1985-12-05 Nonaromatic fluoroallylamine MAO inhibitors

Publications (4)

Publication Number Publication Date
NO864869D0 NO864869D0 (no) 1986-12-04
NO864869L NO864869L (no) 1987-06-09
NO165916B NO165916B (no) 1991-01-21
NO165916C true NO165916C (no) 1991-05-02

Family

ID=25191744

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864869A NO165916C (no) 1985-12-05 1986-12-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive, ikke-aromatiske fluorallylamin mao-inhibitorer.

Country Status (16)

Country Link
US (1) US4650907A (es)
KR (1) KR900006125B1 (es)
CN (1) CN1014515B (es)
AR (1) AR242948A1 (es)
AU (1) AU594722B2 (es)
CA (1) CA1265818A (es)
DK (1) DK167763B1 (es)
FI (1) FI86845C (es)
HU (1) HU199394B (es)
IE (1) IE59058B1 (es)
IL (1) IL80817A (es)
NO (1) NO165916C (es)
NZ (1) NZ218498A (es)
PH (1) PH22545A (es)
PT (1) PT83864B (es)
ZA (1) ZA869057B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338647C (en) * 1988-02-25 1996-10-15 Michael G. Palfreyman Inhibitors of lysyl oxidase
US5059714A (en) * 1988-02-25 1991-10-22 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5252608A (en) * 1988-02-25 1993-10-12 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4965288A (en) * 1988-02-25 1990-10-23 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5120764A (en) * 1988-11-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
WO2004087138A1 (en) * 2003-03-31 2004-10-14 Sucampo Ag Method for treating vascular hyperpermeable disease
US20070254931A1 (en) * 2004-07-27 2007-11-01 Astellas Pharma Inc. Thiazole Derivatives Having Vap-1 Inhibitory Activity
EP1791835A2 (en) * 2004-09-09 2007-06-06 Astellas Pharma Inc. Thiazole derivatives having vap-1 inhibitory activity
JP2011504485A (ja) * 2007-11-21 2011-02-10 ファーマクシス リミテッド Ssao/vap−1のハロアリルアミン阻害剤およびその用途
AU2013255103B2 (en) 2012-05-02 2016-09-29 Pharmaxis Ltd. Substituted 3-haloallylamine inhibitors of SSAO and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454158A (en) * 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors

Also Published As

Publication number Publication date
US4650907A (en) 1987-03-17
DK167763B1 (da) 1993-12-13
CA1265818C (en) 1990-02-13
PT83864B (pt) 1989-01-17
PT83864A (en) 1987-01-01
IL80817A (en) 1991-06-10
AU6581386A (en) 1987-06-11
HUT46293A (en) 1988-10-28
AU594722B2 (en) 1990-03-15
NO864869L (no) 1987-06-09
CA1265818A (en) 1990-02-13
HU199394B (en) 1990-02-28
NO864869D0 (no) 1986-12-04
AR242948A1 (es) 1993-06-30
KR900006125B1 (ko) 1990-08-24
NO165916B (no) 1991-01-21
IE863186L (en) 1987-06-05
FI864962A (fi) 1987-06-06
FI86845B (fi) 1992-07-15
KR870005960A (ko) 1987-07-08
DK583486A (da) 1987-06-06
CN86108051A (zh) 1987-08-19
IL80817A0 (en) 1987-03-31
DK583486D0 (da) 1986-12-04
CN1014515B (zh) 1991-10-30
IE59058B1 (en) 1993-12-15
PH22545A (en) 1988-10-17
FI864962A0 (fi) 1986-12-04
FI86845C (fi) 1992-10-26
NZ218498A (en) 1989-09-27
ZA869057B (en) 1987-07-29

Similar Documents

Publication Publication Date Title
NO163857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindionforbindelser.
NO166367C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO872946D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO164165C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO162113C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser.
NO165397C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO163619C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro- 2-heterocykloalkylpyrido(4,3)indoler.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO166326C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 3,7-substituerte-8-oxo-5-thia-1-azabicyclo-(4,2,0)oct-2-en-2-carboxylater.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO164295C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO165916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, ikke-aromatiske fluorallylamin mao-inhibitorer.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO164172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tienokondenserte forbindelser.
NO873680L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO168530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.
NO865148D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider.
NO164972C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo-1,8-diamino-4-aza-octaner.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2001